Simcere Pharmaceutical Grp Ltd Registered Shares o.N.
- BID
1.46
- ASK
1.5
- 13,699 Units16,666 Units
- 07/21, 09:52:00 AM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
11.11%
Market Cap
-
P/E Ratio
20.37
Dividend Yield
1.73 %
Earnings per Share
0.07 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 1.46 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 09:32:46 AM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 1.46 | 1.42 |
| PREV. DAY'S PRICE | 1.4 | (07/20) |
| CHANGE DAY BEFORE | +0.06 | 4.29 % |
| 52 WEEK HIGH / LOW | 1.65 (08/25) | 0.985 (06/22) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.04 | 0.04 | 0.07 | 0.08 | 0.10 |
DIVIDENDS PER SHARE | 0.02 | 0.02 | 0.02 | - | - |
DIVIDEND YIELD IN % | 2.61 % | 2.46 % | 1.73 % | - | - |
DIVIDEND GROWTH IN % | -2.75 % | -0.24 % | 13.60 % | - | - |
PRICE - EARNINGS RATIO | 22.23 | 22.45 | 20.37 | 17.03 | 13.97 |
PRICE - BOOK RATIO | 2.21 | 2.35 | 2.97 | - | - |
PRICE - SALES RATIO | 2.40 | 2.49 | 3.55 | - | - |
PRICE - CASH FLOW RATIO | 36.08 | 11.24 | 13.40 | - | - |
Master Data
| WKN | A2QD9S |
| ISIN | HK0000658531 |
| SYMBOL | S2P |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | SIMCERE PHARMAC. GRP LTD |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 4.48 % | 37.25 % | 5.26 % | 12.00 % | 11.11 % | 67.66 % | - | 9.38 % |
| HIGH | 1.44 | 1.44 | 1.44 | 1.56 | 1.65 | 1.65 | - | 1.56 |
| LOW | 1.34 | 0.99 | 0.99 | 0.99 | 0.99 | 0.58 | - | 0.99 |
Dividende
pro Aktie
Company profile
Simcere Pharmaceutical Group Ltd. engages in the research, development, manufacturing, and sale of pharmaceutical products. It operates through the Sale of Pharmaceutical Products and Promotion Service Income segments. The Promotion Service Income segment includes the rendering promotion service of pharmaceutical products that are not manufactured by the firm. The company was founded by Jin Sheng Ren in 1995 and is headquartered in Nanjing, China.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.